The neoglycolipid (NGL) technology-based microarrays and future prospects

Area of Science:

• Carbohydrate Chemistry
• Glycomics
• Immunology

Background:

• Neoglycolipid (NGL) technology underpins advanced oligosaccharide microarray systems.
• These systems are crucial for screening and identifying glycan-binding proteins (GBPs) and their ligands.
• Understanding these interactions is vital in immunology, microbiology, and disease diagnostics.

Purpose of the Study:

• To review the development and applications of NGL-based oligosaccharide microarray technology.
• To highlight methods for generating natural glycome arrays to identify novel biologically relevant ligands.
• To showcase the utility of these arrays in studying immune system proteins, bacterial enzymes, and viral adhesins.

Main Methods:

• Development and application of Designer Array and Beam Search Array approaches.
• Utilizing oligosaccharide microarrays for screening and ligand identification.
• Analysis of interactions between glycans and various proteins, including immune effectors, bacterial modules, and viral adhesins.

Main Results:

• Successful identification of ligands for immune effector proteins (Dectin-1, DC-SIGN, DC-SIGNR) and bacterial carbohydrate-binding modules (CBMs).
• Elucidation of the structure of a prostate cancer-associated antigen (F77).
• Identification of ligands for rotavirus adhesins (P[10] and P[19]) on epithelial mucin glycoproteins.

Conclusions:

• NGL-based oligosaccharide microarrays are powerful tools for dissecting complex glycan-protein interactions.
• The technology facilitates the discovery of novel ligands with significant biological and clinical relevance.
• This approach advances our understanding of immune responses, microbial pathogenesis, and cancer biomarkers.